Life Science & Biotech Companies in London

CRISPR genome editing and engineered cell models for research

Prime.io is a contract research organisation providing genome editing services and reagents for drug discovery and functional genomics. Its work includes CRISPR knock-in and knock-out cell line generation, gene editing design, pooled screening and sequencing-based validation. The company develops engineered cellular…

AI-native virtual scientist platform for drug discovery

Kiin Bio is a software company developing an AI-native platform that integrates virtual scientist agents with laboratory databases, modelling software and analysis tools to streamline drug discovery workflows. The platform coordinates tasks spanning literature review, experimental design, bioinformatics and…

Targeted therapies against extrachromosomal DNA in cancer

Econic Biosciences is a drug discovery biotech developing therapies that target extrachromosomal DNA, a circular form of DNA found outside normal chromosomes that drives oncogene amplification, tumour evolution, and treatment resistance across multiple cancer types. The company uses AI to identify and characterise…

Bispecific antibody-drug conjugates for hard-to-treat solid tumours

Valink Therapeutics is a biotechnology company developing next-generation bispecific antibody-drug conjugates and multispecific antibody therapeutics for oncology. Its proprietary discovery platform enables modular assembly of complex antibody formats combining multispecificity, multivalency, and drug conjugation,…

GMP analytical and microbiology testing for pharmaceutical and healthcare products

Aspire Laboratories is an independent, GMP-accredited contract analytical and microbiology testing laboratory based in East London. The company provides quality control testing services including method development and batch release testing, serving clients in the pharmaceutical, cosmetics, veterinary, healthcare and…

Dendritic cell biology platform for cancer and autoimmune therapies

Adendra Therapeutics is a discovery-stage biotechnology company developing small molecule and biologic medicines targeting dendritic cell biology for the treatment of solid tumours and autoimmune diseases. The company's approach is based on research into how dendritic cells regulate adaptive immune responses to cell…

Academic cancer research institute and drug discoverer

The Institute of Cancer Research (ICR) is an independent research institute and member institution of the University of London, specialising in cancer biology, drug discovery, genetics, and precision radiotherapy. Working closely with the Royal Marsden NHS Foundation Trust, the ICR has discovered cancer medicines…

AI-powered drug design engine built on AlphaFold technology

Isomorphic Labs is an artificial intelligence company applying frontier AI to drug discovery, built on and beyond the Nobel Prize-winning AlphaFold protein structure prediction system developed at Google DeepMind. Its proprietary drug design engine spans target identification, molecular design, and binding prediction…

Gene therapy company targeting inherited and degenerative diseases

MeiraGTx is a vertically integrated, clinical-stage genetic medicines company developing AAV-based gene therapies for inherited retinal diseases, neurodegenerative conditions, and salivary gland disorders. The company operates end-to-end capabilities spanning viral vector design, GMP manufacturing, and clinical…

AI-designed enzymes for enzymatic recycling of plastics and textiles

Epoch Biodesign is a London-based industrial biotech developing AI-engineered enzymes for the biorecycling of mixed plastics and textiles. The company's platform uses machine learning to design enzymes that deconstruct waste materials at the molecular level, recovering high-purity chemical building blocks for…

Cell-free biocatalyst platform for sustainable industrial chemical manufacturing

FabricNano is an industrial biotechnology company developing cell-free enzyme catalysts for chemical manufacturing. Its immobilisation engineering platform uses high-throughput screening to identify scalable support materials that improve enzyme stability and activity. Predictive Immobilisation Plates enable…

Small molecule drugs targeting astrocytes in neurodegenerative disease

AstronauTx is a clinical-stage UK biotech developing oral small molecule therapeutics for Alzheimer's disease and other neurodegenerative disorders. The company's approach targets astrocytes, brain support cells whose dysregulated inflammatory activity contributes to neurodegeneration, aiming to restore normal…

Global generics and specialty pharmaceutical manufacturer headquartered in London

Hikma Pharmaceuticals is a multinational pharmaceutical company developing, manufacturing and marketing generic, specialty and branded medicines across injectable, oral and respiratory dosage forms. The company's portfolio spans oncology, cardiovascular, respiratory, pain management and other therapeutic areas,…

London life sciences cluster organisation and inward investment body

MedCity is the cluster organisation for the life sciences sector in London, operating as a division of London & Partners, the Mayor of London's growth agency. Founded in 2014 in partnership with London's Academic Health Science Centres, MedCity promotes London as a global destination for life sciences investment,…

AI platform for drug target safety assessment and toxicity prediction

SableBio is a software company providing an AI-driven target safety intelligence platform for drug discovery teams. The platform analyses large volumes of biomedical data, including unstructured scientific literature, to quantify and prioritise toxicology risks associated with drug targets earlier in the development…

Targeted radiotheranostics for treatment-resistant solid tumours

Nuclide Therapeutics is a King's College London spin-out developing targeted radiopharmaceuticals for treatment-resistant solid tumours. Its radiotheranostic approach uses tumour-binding molecules labelled with diagnostic or therapeutic radionuclides to identify and attack cancer cells. Lead programmes target ALDH1A1…

Colour-changing biochemical swabs for rapid contamination screening

FreshCheck develops patented colour-changing biochemical swabs for rapid verification of surface hygiene in food production and other facilities. Its Hygiene Verification System detects residual microbial and organic contamination, delivering a visual result within seconds without laboratory instrumentation. A…

Preclinical inhibitors of Notch and Mastermind cancer signalling pathways

Anastasis Biotec is a preclinical biotechnology company developing targeted inhibitors of cancer signalling pathways, with a focus on the Notch pathway and its transcriptional co-activator Mastermind. These pathways help drive tumour growth and the survival of cancer stem cells. The company is developing peptide-based…

Gene editing platform restoring disease resistance in crop species

Resurrect Bio is a plant biotechnology company developing disease-resistant crops through a proprietary gene editing platform. Using computational biology and high-throughput plant screening, the company identifies and restores native resistance genes that have been suppressed by pathogens or lost through selective…

AI-designed combination therapies for cancer

Big Picture Bio is a preclinical biotechnology company designing combination therapies for cancer. Its generative model simulates how tumours, immune cells and surrounding tissue interact, and is used to predict which drug combinations, and which sequences of treatment, are most likely to suppress resistant cancer…